Track topics on Twitter Track topics that are important to you
Dallas, TX, February 17, 2017 --(PR.com)-- Global Nerve Regeneration and Repair market is expected to reach USD 18.2 billion by 2024 from USD 7.5 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The nerve regeneration and repair market is segmented into based on product type, indication, end-user and geography.
On the basis of product types the market is segmented into 2 types of biomaterial and neurostimulation segments. The neurostimulation segment dominates the market and is further classified into internal and external neurostimulation devices. Internal neurostimulation devices is further segmented into spinal cord stimulator (SCS), deep brain stimulator (DBS), vagus nerve stimulator (VNS), sacral nerve stimulator (SNS) and gastric nerve stimulator (GNS).
The market is further segmented based on indications into failed back surgery syndrome, conditional regional pain syndrome, eschemia, Parkinson’s disease, Alzheimer’s, urinary incontinence, faecal incontinence, epilepsy, gastroparesis, nerve repair, nerve grafting and others.
Request for sample pages: https://databridgemarketresearch.com/reports/global-nerve-regeneration-and-repair-market-trends-and-forecast-to-2024/
Based on geography the nerve regeneration and repair market is segmented into 6 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Read more https://databridgemarketresearch.com/global-nerve-regeneration-repair-market-poised-grow-11-7-till-2024/
Some of the major players operating in this market are AxoGen, Inc., Boston Scientific Corporation, Alafair Biosciences, BioControl Medical, Medtronic, AxoGen Inc., Boston Scientific Corporation, Baxter International, Checkpoint Surgical Inc., St. Jude Medical, Inc., Integra Lifesciences Corporation, Nevro Corporation, Orthomed S.A.S., Collagen Matrix, Inc., Cyberonics, Inc. Polyganics B.V. and Stryker Corporation among other companies.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Contact via Email
Visit Data Bridge Blog @ http://databridgemarketresearch.com/blog/
Read the full story here: http://www.pr.com/press-release/705508
Press Release Distributed by PR.com
A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic proc...
Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...